» Articles » PMID: 3714523

Immunoglobulin Supplementation in Prevention or Treatment of Neonatal Sepsis

Overview
Specialty Pediatrics
Date 1986 May 1
PMID 3714523
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials.

Henry C, Semova G, Barnes E, Cotter I, Devers T, Rafaee A Pediatr Res. 2022; 91(4):735-742.

PMID: 34997225 PMC: 9064797. DOI: 10.1038/s41390-021-01883-y.


Intravenous immunoglobulin for suspected or proven infection in neonates.

Ohlsson A, Lacy J Cochrane Database Syst Rev. 2020; 1:CD001239.

PMID: 31995649 PMC: 6988993. DOI: 10.1002/14651858.CD001239.pub6.


Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Yang X, Sherwin C, Yu T, Yellepeddi V, Brunner H, Vinks A Expert Rev Clin Pharmacol. 2015; 8(5):587-603.

PMID: 26143647 PMC: 5575755. DOI: 10.1586/17512433.2015.1059751.


Intravenous Immunoglobulin Doesn't Decrease Mortality for Suspected or Proven Sepsis in the Neonate.

Alomran A J Clin Neonatol. 2014; 2(4):163-5.

PMID: 24404526 PMC: 3883209. DOI: 10.4103/2249-4847.123088.


Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Alejandria M, Lansang M, Dans L, Mantaring 3rd J Cochrane Database Syst Rev. 2013; (9):CD001090.

PMID: 24043371 PMC: 6516813. DOI: 10.1002/14651858.CD001090.pub2.